Property:Drop-out reasons
This is a property of type Text.
S
Shokri et al. (2017): Comparison of the Complications of Platinum-Based Adjuvant Chemotherapy With and Without Ginger in a Pilot Study on Ovarian Cancer Patients +
NA +
Shooriabi et al. (2016): The effect of ginger extract on radiotherapy-oriented salivation in patients with xerostomia: A double-blind controlled study +
NA +
Shooriabi et al. (2016): The effect of ginger extract on radiotherapy-oriented salivation in patients with xerostomia: A double-blind controlled study +
NA +
Sontakke et al. (2003): Ginger as an antiemetic in nausea and vomiting induced by chemotherapy: A randomized, cross-over, double blind study +
Died: n = 4,
Drop out during second cycle despite adequate control: n = 2,
No reporting back for second cycle, n = 2 +
Sontakke et al. (2003): Ginger as an antiemetic in nausea and vomiting induced by chemotherapy: A randomized, cross-over, double blind study +
Died, n = 4
Refused to continue chemotherapy due to inadequate control if nausea and vomiting, n = 2
No reporting back for second cycle, n = 2 +
Sontakke et al. (2003): Ginger as an antiemetic in nausea and vomiting induced by chemotherapy: A randomized, cross-over, double blind study +
Died, n = 4
Refused to continue chemotherapy due to inadequate control of nausea and vomiting, n = 2 +
Stauder et al. (1991): Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme +
NI +
Stauder et al. (1991): Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme +
NI +
Stendell-Hollis et al. (2010): Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors +
Not arm specified lost to follow-up: no reasons for study discontinuation (n=4); intolerance or dislike of tea product (n=4); difficulty adhering to study protocol as a result of busy schedules (n=3) +
Stendell-Hollis et al. (2010): Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors +
Not arm specified lost to follow-up: no reasons for study discontinuation (n=4); intolerance or dislike of tea product (n=4); difficulty adhering to study protocol as a result of busy schedules (n=3) +
Stephenson et al. (2000): The Effects of Foot Reflexology on Anxiety and Pain in Patients With Breast and Lung Cancer. +
NI +
Stephenson et al. (2000): The Effects of Foot Reflexology on Anxiety and Pain in Patients With Breast and Lung Cancer. +
NI +
Unable to answer the preintervention visual analog scale and was too agitated to answer any postintervention questions +
Unable to receive the intervention because they were too ill +
Strasser et al. (2006): Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled (…) +
Reason (n):
Withdrawn consent (20)
Serious adverse event (3)
Other exclusion criterion (1)
Death (8)
Loss to follow-up (3) +
Strasser et al. (2006): Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled (…) +
Reason (n):
Withdrawn consent (17)
Serious adverse event (4)
Other exclusion criterion (1)
Death (4)
Loss to follow-up (1)
Other protocol violation (2) +
Strasser et al. (2006): Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled (…) +
Reason (n):
Withdrawn consent (8)
Serious adverse event (4)
Other exclusion criterion (2)
Death (1) +
Stratton et al. (2010): Oral Selenium Supplementation Has No Effect on Prostate- Specific Antigen Velocity in Men Undergoing Active Surveillance for Localized Prostate Cancer +
8 completed study; 14 reached study endpoint, 14 on study at study end, 1 died, 2 concurrent illness, 4 withdrew for reasons not study-related, 3 withdrew for other study-related reasons +
Stratton et al. (2010): Oral Selenium Supplementation Has No Effect on Prostate- Specific Antigen Velocity in Men Undergoing Active Surveillance for Localized Prostate Cancer +
9 completed study; 18 reached study endpoint, 7 on study at study end, 2 died, 2 concurrent illness, 4 withdrew for reasons not study-related, 5 withdrew for other study-related reasons +
Stratton et al. (2010): Oral Selenium Supplementation Has No Effect on Prostate- Specific Antigen Velocity in Men Undergoing Active Surveillance for Localized Prostate Cancer +
12 completed study; 13 reached study endpoint, 6 on study at study end, 2 died, 2 concurrent illness, 6 withdrew for reasons not study-related, 6 withdrew for other study-related reasons +